BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2011
View Archived Issues
Eisai's Halaven injection approved in Singapore for metastatic breast cancer
Read More
Cardiac imaging using [123I]-mIBG can predict development of permanent atrial fibrillation
Read More
Dextran-coated iron oxide nanoparticles detect cholera enterotoxin with high sensitivity
Read More
Homocysteine level in serum is a biomarker for extent of vitiligo
Read More
Aptamer-targeted nanoparticle-encapsulated cisplatin prodrug shows promise in vivo
Read More
New inverse agonist of RAR-related orphan receptor-alpha SR-3335 improves glucose homeostasis
Read More
BioAlliance Pharma reports preliminary data from survey in patients with herpes labialis
Read More
PolyMedix begins phase II trial of PMX-60056 for reversal of heparin action in surgical setting
Read More
Teva Pharma reports phase III data on Qnaze in perennial allergic rhinitis
Read More
Novel urotensin UT receptor antagonists claimed by sanofi-aventis
Read More
CeNeRx presents first-in-human results on CXB-909
Read More
Cytokinetics and Amgen divulge design of phase IIb trial of intravenous omecamtiv mecarbil
Read More
Cephalon and Alba Therapeutics enter option agreement for larazotide acetate
Read More
GeoVax opens second site for ongoing HIV vaccine trial
Read More
First patient treated in CMV-ACE/ASPECT trial of preemptive cell therapy for CMV infection
Read More
Amicus Therapeutics begins phase II trial of Amigal plus ERT in Fabry's disease
Read More
European orphan drug status recommended for QLT-091001 in LCA and RP
Read More
Evotec enters definitive agreement to acquire Kinaxo Biotechnologies
Read More
Anacor and Medicis to collaborate on development of acne treatments
Read More
Futura Medical and Ansell enter commercialization agreement for PET-500
Read More
Eisai and Bial launch antiepileptic Zebinix in Spain
Read More